Identification |
Name: | L-Lyxonamide,2,4,5-trideoxy-4-[[3,3-dimethyl-1-oxo-2-[[(1,3,4-thiadiazol-2-ylthio)acetyl]amino]butyl]amino]-N-[1-[[[(2-hydroxy-4-methoxyphenyl)methyl]amino]carbonyl]-2-methylpropyl]-2-[[(4-methoxyphenyl)methyl]amino]-5-phenyl-,[1(S),4(S)]- (9CI) |
Synonyms: | 169305-70-8;(2R,3S,4S)-N-(4-(3-hydroxy-2-(4-methoxybenzylamino)((N-((5-methyl-1,3,4,-thiadiazol-2-thioacetyl)tert.leucinyl)amino)-5-phenylpentanoyl)valine 2-Hydroxy-4-methoxybenzylamide;(2R,3S,4S)-N-[4-[3-hydroxy-2-(4-methoxybenzylamino)[[N-[(5-methyl-1,3,4,-thiadiazol-2-thioacetyl)tert.leucinyl]amino]-5-phenylpentanoyl]valine 2-Hydroxy-4-methoxybenzylamide;AC1LA5OX;nyl)methyl]amino]-5-phenyl-, [1(S),4(S)]-;(2S)-N-[(2S,3R,4R)-3-hydroxy-5-[[(2S)-1-[(2-hydroxy-4-methoxyphenyl)methylamino]-3-methyl-1-oxobutan-2-yl]amino]-4-[(4-methoxyphenyl)methylamino]-5-oxo-1-phenylpentan-2-yl]-3,3-dimethyl-2-[[2-(1,3,4-thiadiazol-2-ylsulfanyl)acetyl]amino]butanamide;L-Lyxonamide, 2,4,5-trideoxy-4-((3,3-dimethyl-1-oxo-2-(((1,3,4-thiadiazol-2-ylthio)acetyl)amino)butyl)amino)-N-(1-((((2-hydroxy-4-methoxyphenyl)methyl)amino)carbonyl)-2-methylpropyl)-2-(((4-methoxyphenyl)methyl)amino)-5-phenyl-, (1(S),4(S))-;L-Lyxonamide, 2,4,5-trideoxy-4-[[3,3-dimethyl-1-oxo-2-[[(1,3,4-thiadiazol-2-ylthio)acetyl]amino]butyl]amino]-N-[1-[[[(2-hydroxy-4-methoxyphenyl)methyl]amino]carbonyl]-2-methylpropyl]-2-[[(4-methoxyphe |
CAS: | 169305-70-8 |
Molecular Formula: | C42H55 N7 O8 S2 |
Molecular Weight: | 850.0582 |
InChI: | InChI=1/C42H55N7O8S2/c1-25(2)34(38(53)44-22-28-15-18-30(57-7)20-32(28)50)48-39(54)35(43-21-27-13-16-29(56-6)17-14-27)36(52)31(19-26-11-9-8-10-12-26)46-40(55)37(42(3,4)5)47-33(51)23-58-41-49-45-24-59-41/h8-18,20,24-25,31,34-37,43,50,52H,19,21-23H2,1-7H3,(H,44,53)(H,46,55)(H,47,51)(H,48,54)/t31-,34-,35+,36+,37+/m0/s1 |
Molecular Structure: |
|
Properties |
Flash Point: | °C |
Boiling Point: | °Cat760mmHg |
Density: | 1.31g/cm3 |
Refractive index: | 1.629 |
Flash Point: | °C |
Safety Data |
|
|